FDA Unveils Guidance To Smooth Generic-Drug Path
The U.S. Food and Drug Administration on Wednesday unveiled draft guidance for the pharmaceutical industry and an internal manual of policies and procedures that it says will streamline the approval process...To view the full article, register now.
Already a subscriber? Click here to view full article